PubRank

Patricia Flynn

Author PubWeight™ 25.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009 11.12
2 Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother 2005 1.59
3 Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer 2008 1.46
4 Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother 2007 1.28
5 Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 2010 1.14
6 Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS 2009 1.13
7 Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics 2007 1.08
8 Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab 2012 1.04
9 Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination. Vaccine 2010 0.96
10 Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics 2014 0.89
11 Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul 2009 0.87
12 Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses 2010 0.86
13 Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 2012 0.84
14 Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine. Int Rev Immunol 2009 0.83
15 Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth. AIDS 2016 0.79
16 Cephalosporin-resistant pneumococci and sickle cell disease. Emerg Infect Dis 2005 0.78
17 Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants. Pediatr Infect Dis J 2003 0.75